These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37586941)

  • 1. Emerging autophagic endo-lysosomal targets in the management of Parkinson's disease.
    Siddiqui T; Bhatt LK
    Rev Neurol (Paris); 2024 Jun; 180(6):477-485. PubMed ID: 37586941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Emerging Role of the Lysosome in Parkinson's Disease.
    Navarro-Romero A; Montpeyó M; Martinez-Vicente M
    Cells; 2020 Nov; 9(11):. PubMed ID: 33147750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies.
    Xilouri M; Brekk OR; Stefanis L
    Mov Disord; 2016 Feb; 31(2):178-92. PubMed ID: 26813776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.
    Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein and Glia in Parkinson's Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System?
    Filippini A; Gennarelli M; Russo I
    Cell Mol Neurobiol; 2019 Mar; 39(2):161-168. PubMed ID: 30637614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.
    Murphy KE; Gysbers AM; Abbott SK; Tayebi N; Kim WS; Sidransky E; Cooper A; Garner B; Halliday GM
    Brain; 2014 Mar; 137(Pt 3):834-48. PubMed ID: 24477431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-Synuclein and the Endolysosomal System in Parkinson's Disease: Guilty by Association.
    Teixeira M; Sheta R; Idi W; Oueslati A
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
    Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
    Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction.
    Bellomo G; Paciotti S; Gatticchi L; Parnetti L
    Mov Disord; 2020 Jan; 35(1):34-44. PubMed ID: 31729779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies.
    Manzoni C; Lewis PA
    FASEB J; 2013 Sep; 27(9):3424-9. PubMed ID: 23682122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cleaning Crew: The Pursuit of Autophagy in Parkinson's Disease.
    Parekh P; Sharma N; Gadepalli A; Shahane A; Sharma M; Khairnar A
    ACS Chem Neurosci; 2019 Sep; 10(9):3914-3926. PubMed ID: 31385687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrillar α-synuclein toxicity depends on functional lysosomes.
    Guiney SJ; Adlard PA; Lei P; Mawal CH; Bush AI; Finkelstein DI; Ayton S
    J Biol Chem; 2020 Dec; 295(51):17497-17513. PubMed ID: 33453994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.
    Wong YC; Krainc D
    Mov Disord; 2016 Nov; 31(11):1610-1618. PubMed ID: 27619775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease.
    Wu F; Xu HD; Guan JJ; Hou YS; Gu JH; Zhen XC; Qin ZH
    Neuroscience; 2015 Jan; 284():900-911. PubMed ID: 25446361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons.
    Fernandes HJ; Hartfield EM; Christian HC; Emmanoulidou E; Zheng Y; Booth H; Bogetofte H; Lang C; Ryan BJ; Sardi SP; Badger J; Vowles J; Evetts S; Tofaris GK; Vekrellis K; Talbot K; Hu MT; James W; Cowley SA; Wade-Martins R
    Stem Cell Reports; 2016 Mar; 6(3):342-56. PubMed ID: 26905200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrograde Axonal Autophagy and Endocytic Pathways Are Parallel and Separate in Neurons.
    Kulkarni VV; Stempel MH; Anand A; Sidibe DK; Maday S
    J Neurosci; 2022 Nov; 42(45):8524-8541. PubMed ID: 36167783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Autophagic-Lysosomal Fusion in Parkinson's Patient Midbrain Neurons Occurs through Loss of ykt6 and Is Rescued by Farnesyltransferase Inhibition.
    Pitcairn C; Murata N; Zalon AJ; Stojkovska I; Mazzulli JR
    J Neurosci; 2023 Apr; 43(14):2615-2629. PubMed ID: 36788031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis.
    Xilouri M; Vogiatzi T; Vekrellis K; Stefanis L
    Autophagy; 2008 Oct; 4(7):917-9. PubMed ID: 18708765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lysosomal membrane protein LAMP2A promotes autophagic flux and prevents SNCA-induced Parkinson disease-like symptoms in the Drosophila brain.
    Issa AR; Sun J; Petitgas C; Mesquita A; Dulac A; Robin M; Mollereau B; Jenny A; Chérif-Zahar B; Birman S
    Autophagy; 2018; 14(11):1898-1910. PubMed ID: 29989488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIT2 regulates autophagy lysosomal pathway induction and protects against α-synuclein pathology in a cellular model of Parkinson's disease.
    Gao AYL; Montagna DR; Hirst WD; Temkin PA
    Neurobiol Dis; 2024 Sep; 199():106568. PubMed ID: 38885848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.